1. Home
  2. XTNT vs YI Comparison

XTNT vs YI Comparison

Compare XTNT & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

HOLD

Current Price

$0.47

Market Cap

68.9M

Sector

Health Care

ML Signal

HOLD

Logo 111 Inc.

YI

111 Inc.

HOLD

Current Price

$5.40

Market Cap

57.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XTNT
YI
Founded
N/A
2010
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Retail-Drug Stores and Proprietary Stores
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
68.9M
57.1M
IPO Year
2009
2018

Fundamental Metrics

Financial Performance
Metric
XTNT
YI
Price
$0.47
$5.40
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
150.9K
15.4K
Earning Date
05-08-2026
04-09-2026
Dividend Yield
N/A
N/A
EPS Growth
125.00
N/A
EPS
N/A
N/A
Revenue
$53,337,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.44
$2.48
52 Week High
$0.95
$11.17

Technical Indicators

Market Signals
Indicator
XTNT
YI
Relative Strength Index (RSI) 39.92 36.20
Support Level $0.44 $4.31
Resistance Level $0.67 $7.18
Average True Range (ATR) 0.03 0.47
MACD -0.00 -0.03
Stochastic Oscillator 19.73 34.44

Price Performance

Historical Comparison
XTNT
YI

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

About YI 111 Inc.

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

Share on Social Networks: